Malin Corporation | MLC - Beneficio Operativo





Beneficio Operativo Cambio Fecha
Akebia Therapeutics USD -5.45M 9.4M 2025-12
Alaunos Therapeutics USD -1.01M 175K 2026-03
ALKERMES USD -65.93M 17.65M 2026-06
Avita Medical AUD -10.41M 742K 2025-12
Dianthus Therapeutics USD -46.53M 23.01M 2026-03
Eurofins Scientific SE EUR 500M 108.7M 2026-06
Ionis Pharmaceuticals USD -102.29M 15.71M 2026-06
IQVIA Holdings USD 2.6B 2.03B 2026-06
Lonza CHF 673M 243M 2025-06
Malin Corporation EUR -1.1M 400K 2024-12
Moderna USD -815M 573M 2026-06
Organon & Co USD 266M 49M 2026-03
Ovoca Bio EUR -1.16M 4.48M 2025-06
Revvity USD 82.77M 63.06M 2026-03
Tectonic Therapeutic USD -27.3M 5.78M 2026-03
Viatris USD -20.2M 137.3M 2026-03
Xeris Pharmaceuticals USD 7.92M 8.86M 2026-03